ANI Pharmaceuticals Inc (ANIP) — Cash Flow Quality Index
ANI Pharmaceuticals Inc (ANIP) has a Cash Flow Quality Index of 1.10x as of December 2025. Operating cash flow of $30.37 Million exceeds net income of $27.49 Million, indicating high earnings quality where cash backs reported profits. Explore long-term investment intensity of ANI Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ANI Pharmaceuticals Inc Cash Flow Quality Index (2006–2025)
Historical Cash Flow Quality Index for ANI Pharmaceuticals Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ANI Pharmaceuticals Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ANI Pharmaceuticals Inc (2006–2025)
Year-by-year earnings quality comparison for ANI Pharmaceuticals Inc. For live market cap and the full company financial profile, see ANI Pharmaceuticals Inc (ANIP) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.36x | $185.22 Million | $78.34 Million | ▼ -62.7% |
| 2023 | 6.33x | $118.96 Million | $18.78 Million | ▼ -15.4% |
| 2019 | 7.49x | $45.63 Million | $6.09 Million | ▲ +73.0% |
| 2018 | 4.33x | $67.07 Million | $15.49 Million | ▼ -38.0% |
| 2016 | 6.98x | $27.47 Million | $3.93 Million | ▲ +521.9% |
| 2015 | 1.12x | $17.26 Million | $15.38 Million | ▲ +46.5% |
| 2014 | 0.77x | $22.03 Million | $28.75 Million | ▲ +104.2% |
| 2013 | -18.22x | $-5.48 Million | $301.00K | ▼ -917.8% |
| 2006 | -1.79x | $-5.00 Million | $2.79 Million | — |